Drug Shortage Report for MOSASPRAY
Report ID | 86408 |
Drug Identification Number | 02455870 |
Brand name | MOSASPRAY |
Common or Proper name | MOSASPRAY |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MOMETASONE FUROATE |
Strength(s) | 50MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 140 DOS |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-05-27 |
Estimated end date | 2019-06-17 |
Actual end date | 2019-06-14 |
Shortage status | Resolved |
Updated date | 2019-06-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-06-12 | English | Compare |
v2 | 2019-06-12 | French | Compare |
v3 | 2019-06-28 | English | Compare |
v4 | 2019-06-28 | French | Compare |
Showing 1 to 4 of 4